ZA200106444B - Method for controlling lipsome size. - Google Patents
Method for controlling lipsome size.Info
- Publication number
- ZA200106444B ZA200106444B ZA200106444A ZA200106444A ZA200106444B ZA 200106444 B ZA200106444 B ZA 200106444B ZA 200106444 A ZA200106444 A ZA 200106444A ZA 200106444 A ZA200106444 A ZA 200106444A ZA 200106444 B ZA200106444 B ZA 200106444B
- Authority
- ZA
- South Africa
- Prior art keywords
- lipsome
- controlling
- size
- solvent
- lipid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Dispersion Chemistry (AREA)
- Communicable Diseases (AREA)
- Obesity (AREA)
- Reproductive Health (AREA)
- Tropical Medicine & Parasitology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11922999P | 1999-02-08 | 1999-02-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200106444B true ZA200106444B (en) | 2002-08-06 |
Family
ID=22383233
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200106444A ZA200106444B (en) | 1999-02-08 | 2001-08-06 | Method for controlling lipsome size. |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1150658B1 (xx) |
JP (1) | JP2002536316A (xx) |
KR (1) | KR20010101837A (xx) |
CN (1) | CN1198589C (xx) |
AT (1) | ATE272392T1 (xx) |
AU (1) | AU773515B2 (xx) |
CA (1) | CA2361551A1 (xx) |
DE (1) | DE60012693T2 (xx) |
ES (1) | ES2225094T3 (xx) |
HK (1) | HK1040642A1 (xx) |
HU (1) | HUP0200421A3 (xx) |
IL (2) | IL144756A0 (xx) |
NO (1) | NO20013862L (xx) |
WO (1) | WO2000045791A2 (xx) |
ZA (1) | ZA200106444B (xx) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7879351B2 (en) * | 2002-10-29 | 2011-02-01 | Transave, Inc. | High delivery rates for lipid based drug formulations, and methods of treatment thereof |
US7718189B2 (en) | 2002-10-29 | 2010-05-18 | Transave, Inc. | Sustained release of antiinfectives |
JP2006508126A (ja) * | 2002-11-06 | 2006-03-09 | アザヤ セラピューティクス インコーポレイティッド | 薬学的製剤のタンパク質安定化されたリポソーム製剤 |
WO2004096140A2 (en) * | 2003-04-25 | 2004-11-11 | The Penn State Research Foundation | Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds |
JP2006193461A (ja) * | 2005-01-13 | 2006-07-27 | Pola Chem Ind Inc | 毛髪用の洗浄料 |
KR100684380B1 (ko) * | 2005-05-24 | 2007-02-20 | 한국화학연구원 | 빗살형 폴리에틸렌글리콜을 결합한 리포솜 및 이의 제조방법 |
PL1962805T3 (pl) | 2005-12-08 | 2017-01-31 | Insmed Incorporated | Kompozycje środków przeciwzapalnych oparte na lipidach do leczenia infekcji płucnych |
EP2012750B1 (en) * | 2006-04-06 | 2018-02-21 | Insmed Incorporated | Methods for coacervation induced liposomal encapsulation and formulations thereof |
WO2008137717A1 (en) | 2007-05-04 | 2008-11-13 | Transave, Inc. | Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof |
US9119783B2 (en) | 2007-05-07 | 2015-09-01 | Insmed Incorporated | Method of treating pulmonary disorders with liposomal amikacin formulations |
US9333214B2 (en) | 2007-05-07 | 2016-05-10 | Insmed Incorporated | Method for treating pulmonary disorders with liposomal amikacin formulations |
US9114081B2 (en) | 2007-05-07 | 2015-08-25 | Insmed Incorporated | Methods of treating pulmonary disorders with liposomal amikacin formulations |
EP2317981B1 (en) | 2008-07-24 | 2013-11-13 | Amorepacific Corporation | Multi-layered lamellar granule and skin external application composition containing same |
KR20110110086A (ko) * | 2008-12-24 | 2011-10-06 | 가부시키가이샤 바이오메드코어 | 리포솜의 제조방법 및 콜레스테롤의 용해방법 |
JP5771366B2 (ja) * | 2009-09-02 | 2015-08-26 | 株式会社バイオメッドコア | リポソーム製造装置及び方法 |
WO2011162093A1 (ja) * | 2010-06-23 | 2011-12-29 | 学校法人神奈川大学 | 乳化物製造用親水性ナノ粒子の製造方法 |
KR101130754B1 (ko) * | 2010-06-25 | 2012-03-28 | 제일약품주식회사 | 난용성 트리사이클릭 유도체 화합물의 용해도가 향상된 약학적 조성물 |
KR102277921B1 (ko) | 2012-05-21 | 2021-07-14 | 인스메드 인코포레이티드 | 폐 감염을 치료하기 위한 시스템 |
WO2014028087A1 (en) * | 2012-08-17 | 2014-02-20 | University Of Houston | Liposomal formulations of polymyxin and uses thereof |
JP6332902B2 (ja) * | 2012-10-29 | 2018-05-30 | 株式会社ピカソ美化学研究所 | 美容用組成物 |
CA2891487A1 (en) | 2012-11-29 | 2014-06-05 | Insmed Incorporated | Stabilized vancomycin formulations |
KR20160055259A (ko) * | 2013-09-13 | 2016-05-17 | 아버 테라퓨틱스 엘엘씨 | 암 화학요법의 친유성 약물 및 산 불안정성, 친유성 전구약물의 표적화된 전달을 위한 나노미립자 조성물 및 그의 제조 |
PL3142643T3 (pl) | 2014-05-15 | 2019-12-31 | Insmed Incorporated | Sposoby leczenia zakażeń płuc prątkami niegruźliczymi |
CN111565833B (zh) * | 2017-11-01 | 2023-04-07 | 国立大学法人大阪大学 | 用于制造具有期望的粒径的脂质颗粒的方法及装置的开发 |
WO2019191627A1 (en) | 2018-03-30 | 2019-10-03 | Insmed Incorporated | Methods for continuous manufacture of liposomal drug products |
CN114588125B (zh) * | 2022-02-25 | 2023-02-28 | 北京科技大学 | 靶向载药溶栓微泡及其制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61189215A (ja) * | 1985-02-18 | 1986-08-22 | Teijin Ltd | 5−フルオロ−2′−デオキシウリジンエステル類の油状医薬組成物 |
DE4013580A1 (de) * | 1990-04-24 | 1991-10-31 | Schering Ag | Verfahren zur herstellung von wirkstoffhaltigen waessrigen liposomensuspensionen |
RU2085192C1 (ru) * | 1993-02-03 | 1997-07-27 | Экспериментальное предприятие медико-биологических препаратов Кардиологического научного центра РАМН | Способ получения липосомальной формы альфа-токоферола и гомогенизирующий клапан для его осуществления |
ES2154680T3 (es) * | 1993-07-08 | 2001-04-16 | Liposome Co Inc | Metodo para controlar el tamaño de los liposomas. |
US5902604A (en) * | 1995-06-06 | 1999-05-11 | Board Of Regents, The University Of Texas System | Submicron liposome suspensions obtained from preliposome lyophilizates |
JP2002508765A (ja) * | 1997-06-23 | 2002-03-19 | アルザ コーポレイション | リポソーム被包ポリヌクレオチド組成物および方法 |
-
2000
- 2000-02-03 KR KR1020017010024A patent/KR20010101837A/ko not_active Application Discontinuation
- 2000-02-03 CN CNB008035075A patent/CN1198589C/zh not_active Expired - Fee Related
- 2000-02-03 WO PCT/US2000/003039 patent/WO2000045791A2/en not_active Application Discontinuation
- 2000-02-03 HU HU0200421A patent/HUP0200421A3/hu unknown
- 2000-02-03 ES ES00907183T patent/ES2225094T3/es not_active Expired - Lifetime
- 2000-02-03 AT AT00907183T patent/ATE272392T1/de not_active IP Right Cessation
- 2000-02-03 CA CA002361551A patent/CA2361551A1/en not_active Abandoned
- 2000-02-03 AU AU28718/00A patent/AU773515B2/en not_active Ceased
- 2000-02-03 DE DE2000612693 patent/DE60012693T2/de not_active Expired - Fee Related
- 2000-02-03 JP JP2000596911A patent/JP2002536316A/ja active Pending
- 2000-02-03 EP EP00907183A patent/EP1150658B1/en not_active Expired - Lifetime
- 2000-02-03 IL IL14475600A patent/IL144756A0/xx active IP Right Grant
-
2001
- 2001-08-06 ZA ZA200106444A patent/ZA200106444B/xx unknown
- 2001-08-06 IL IL144756A patent/IL144756A/en not_active IP Right Cessation
- 2001-08-08 NO NO20013862A patent/NO20013862L/no not_active Application Discontinuation
-
2002
- 2002-04-04 HK HK02102545A patent/HK1040642A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ATE272392T1 (de) | 2004-08-15 |
WO2000045791A2 (en) | 2000-08-10 |
AU2871800A (en) | 2000-08-25 |
CN1338923A (zh) | 2002-03-06 |
DE60012693D1 (de) | 2004-09-09 |
KR20010101837A (ko) | 2001-11-14 |
HUP0200421A3 (en) | 2005-04-28 |
AU773515B2 (en) | 2004-05-27 |
WO2000045791A3 (en) | 2000-12-21 |
IL144756A0 (en) | 2002-06-30 |
EP1150658B1 (en) | 2004-08-04 |
DE60012693T2 (de) | 2005-01-13 |
NO20013862D0 (no) | 2001-08-08 |
ES2225094T3 (es) | 2005-03-16 |
CN1198589C (zh) | 2005-04-27 |
HUP0200421A2 (en) | 2002-06-29 |
HK1040642A1 (en) | 2002-06-21 |
IL144756A (en) | 2007-06-03 |
JP2002536316A (ja) | 2002-10-29 |
EP1150658A2 (en) | 2001-11-07 |
NO20013862L (no) | 2001-10-08 |
CA2361551A1 (en) | 2000-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200106444B (en) | Method for controlling lipsome size. | |
CA2250219A1 (en) | Materials and methods for making improved liposome compositions | |
IE801201L (en) | Cementitious product. | |
DE69938875D1 (xx) | ||
CA2355269A1 (en) | Materials and methods for making improved micelle compositions | |
AU658619B2 (en) | Benzopyranones, methods of manufacture and use thereof | |
MY123986A (en) | Method and composition for producing set gypsum-containing product with increased strenght, rigidity, and dimensional stability | |
MY115679A (en) | Process for preparing intermediates to florfenicol | |
ZA921875B (en) | New esters of bi- and tricyclic amino alcohols, their preparation and their use in pharmaceutical compositions | |
AU2127697A (en) | Method of preparing polynucleotide-carrier complexes for delivery to cells | |
WO2000057900A3 (en) | Factor for regulation of neurite growth | |
AU3922193A (en) | Liposome encapsulated taxol and a method of using the same | |
DK0843547T3 (da) | Fremgangsmåder til at fremstille liposomer, der indeholder hydromonobenzoporphyrin- fotosensibilisatorer | |
AU4114589A (en) | A method for producing a cementitious composition in powder form | |
MXPA02012604A (es) | Derivados de 5,6-dihidro-piron fenil-substituidos como pesticidas y herbicidas. | |
SG45207A1 (en) | Method for preparing interferon alpha-2 crystals | |
MY117090A (en) | Substituted benzamidines, their preparation and their use as pharmaceutical compounds | |
CA2133366A1 (en) | Lightweight cement blocks and method of producing same | |
AU1791297A (en) | Phosphatidyl oligoglycerols | |
RU95101844A (ru) | Способ получения высокочистого порошка металла | |
AU6725898A (en) | Bonding agent preparations for paints, the production and use thereof | |
AU3776999A (en) | Biologically-active microdispersion composition | |
MX9801133A (es) | Agente endoparasiticida a base de didepsipeptidos, nuevos didepsipeptidos y procedimiento para su produccion. | |
PT1372396E (pt) | Composição pesticida | |
ES8608918A1 (es) | Un procedimiento para fabricar espuma rigida de poliuretano y-o de poliisocianurato |